Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?

Brenda F. Kurland and Steffi Oesterreich
Journal of Nuclear Medicine August 2018, 59 (8) 1210-1211; DOI: https://doi.org/10.2967/jnumed.118.214304
Brenda F. Kurland
1Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania
2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steffi Oesterreich
2UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania; and
3Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 59 no. 8 1210-1211
DOI 
https://doi.org/10.2967/jnumed.118.214304
PubMed 
29903931

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 8, 2018
  • Accepted for publication June 13, 2018
  • Published online August 2, 2018.

Article Versions

  • previous version (June 14, 2018 - 17:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Heterogeneity of estrogen receptor based on 18F-FES PET imaging in breast cancer patients
    Wanting Hao, Yaming Li, Bulin Du, Xuena Li
    Clinical and Translational Imaging 2021 9 6
  • ER status conversion and subsequent treatment: an assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors
    Shuhui You, Yizhao Xie, Mengjing Ji, Cheng Liu, Yannan Zhao, Chengcheng Gong, Shihui Hu, Yumeng Li, Zhongyi Yang, Biyun Wang
    Therapeutic Advances in Medical Oncology 2023 15
  • [18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer
    Poorni M. Manohar, Lanell M. Peterson, Isaac C. Jenkins, Qian Vicky Wu, Brenda F. Kurland, Alena Novakova-Jiresova, Mark Muzi, Delphine L. Chen, Jennifer M. Specht, Suzanne Dintzis, Paul E. Kinahan, David A. Mankoff, Hannah M. Linden
    Molecular Imaging and Biology 2025

Article usage

Article usage: June 2018 to April 2025

AbstractFullPdf
Jun 20181039
Jul 20180012
Aug 20181172101
Sep 2018017540
Oct 201809529
Nov 201808214
Dec 201801027
Jan 20190959
Feb 201948112
Mar 20190997
Apr 20190703
May 201902412
Jun 20190277
Jul 201906215
Aug 20190207
Sep 201901613
Oct 201901610
Nov 20190129
Dec 20190119
Jan 20200138
Feb 20200167
Mar 202001515
Apr 20200136
May 20200143
Jun 202001612
Jul 2020084
Aug 20200107
Sep 2020092
Oct 20200157
Nov 2020072
Dec 20200176
Jan 20210556
Feb 20210148
Mar 20210125
Apr 20210185
May 202101810
Jun 20210163
Jul 202101119
Aug 2021084
Sep 20210179
Oct 20210621
Nov 202101622
Dec 202102014
Jan 20220113
Feb 20220125
Mar 202201110
Apr 202201414
May 202201614
Jun 202201315
Jul 20220208
Aug 202201111
Sep 20220811
Oct 2022089
Nov 202201314
Dec 20220154
Jan 202301010
Feb 20230125
Mar 202301513
Apr 20230279
May 202301311
Jun 2023041
Jul 202301610
Aug 2023049
Sep 2023044
Oct 2023031
Nov 20230914
Dec 20230111
Jan 20240113
Feb 2024014
Mar 20240735
Apr 202401512
May 20240174
Jun 20240155
Jul 202401714
Aug 2024094
Sep 20240186
Oct 202402211
Nov 20240188
Dec 20240106
Jan 2025056
Feb 20250328
Mar 202502514
Apr 202501711
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (8)
Journal of Nuclear Medicine
Vol. 59, Issue 8
August 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?
Brenda F. Kurland, Steffi Oesterreich
Journal of Nuclear Medicine Aug 2018, 59 (8) 1210-1211; DOI: 10.2967/jnumed.118.214304

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?
Brenda F. Kurland, Steffi Oesterreich
Journal of Nuclear Medicine Aug 2018, 59 (8) 1210-1211; DOI: 10.2967/jnumed.118.214304
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • 18F-Fluoroestradiol Tumor Uptake Is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology

  • Radioimmunotherapy in Oncology
  • The Role of NAC FDG-PET/CT in Detecting Cutaneous Lesions
  • Quantitative assessment of radiation therapy-induced cardiovascular complications with FDG-PET and NaF-PET imaging in lung cancer and other thoracic malignancies
Show more Oncology

Clinical

  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
Show more Clinical

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire